Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study
- 31 August 2005
- Vol. 66 (2) , 386-391
- https://doi.org/10.1016/j.urology.2005.03.040
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Ingredients for Prostate Cancer Nomograms: The Addition of Biomarkers Sets the Table for Future RecipesJournal of Clinical Oncology, 2003
- The Addition of Interleukin-6 Soluble Receptor and Transforming Growth Factor Beta1 Improves a Preoperative Nomogram for Predicting Biochemical Progression in Patients With Clinically Localized Prostate CancerJournal of Clinical Oncology, 2003
- Neuroendocrine Expression in Node Positive Prostate Cancer: Correlation With Systemic Progression and Patient SurvivalJournal of Urology, 2002
- Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinomaThe Prostate, 2002
- CHROMOGRANIN A CONCENTRATION AS A SERUM MARKER TO PREDICT PROGNOSIS AFTER ENDOCRINE THERAPY FOR PROSTATE CANCERJournal of Urology, 2002
- Neuroendocrine cells in human prostate over‐express the anti‐apoptosis protein survivinThe Prostate, 2001
- The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine TherapyJournal of Urology, 1997
- Plasma Chromogranin a in Prostatic Carcinoma and Neuroendocrine TumorsJournal of Urology, 1997
- The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long‐term follow‐up study with patients treated by radical prostatectomyInternational Journal of Cancer, 1995
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958